(Q36473826)

English

Impact of cytokine administration on the generation of antitumor reactivity in patients with metastatic melanoma receiving a peptide vaccine

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 August 2017

Impact of cytokine administration on the generation of antitumor reactivity in patients with metastatic melanoma receiving a peptide vaccine (English)

1 reference

Europe PubMed Central

14 August 2017

metastatic melanoma

1 reference

based on heuristic

inferred from title

author name string

S A Rosenberg

1

1 reference

Europe PubMed Central

14 August 2017

J C Yang

2

1 reference

Europe PubMed Central

14 August 2017

D J Schwartzentruber

3

1 reference

Europe PubMed Central

14 August 2017

P Hwu

4

1 reference

Europe PubMed Central

14 August 2017

F M Marincola

5

1 reference

Europe PubMed Central

14 August 2017

S L Topalian

6

1 reference

Europe PubMed Central

14 August 2017

N P Restifo

7

1 reference

Europe PubMed Central

14 August 2017

M Sznol

8

1 reference

Europe PubMed Central

14 August 2017

S L Schwarz

9

1 reference

Europe PubMed Central

14 August 2017

P J Spiess

10

1 reference

Europe PubMed Central

14 August 2017

J R Wunderlich

11

1 reference

Europe PubMed Central

14 August 2017

C A Seipp

12

1 reference

Europe PubMed Central

14 August 2017

J H Einhorn

13

1 reference

Europe PubMed Central

14 August 2017

L Rogers-Freezer

14

1 reference

Europe PubMed Central

14 August 2017

D E White

15

1 reference

Europe PubMed Central

14 August 2017

language of work or name

0 references

publication date

1 August 1999

1 reference

Europe PubMed Central

14 August 2017

Journal of Immunology

1 reference

Europe PubMed Central

14 August 2017

163

1 reference

Europe PubMed Central

14 August 2017

1690-1695

1 reference

Europe PubMed Central

14 August 2017

3

1 reference

Europe PubMed Central

14 August 2017

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2249693

30 September 2017

Development of cancer immunotherapies based on identification of the genes encoding cancer regression antigens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2249693

30 September 2017

Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2249693

30 September 2017

Therapeutic antitumor response after immunization with a recombinant adenovirus encoding a model tumor-associated antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2249693

30 September 2017

Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2249693

30 September 2017

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2249693

30 September 2017

Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2249693

30 September 2017

Influence of interleukin 12 on p53 peptide vaccination against established Meth A sarcoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2249693

30 September 2017

IL-2 enhances the function of recombinant poxvirus-based vaccines in the treatment of established pulmonary metastases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2249693

30 September 2017

Genes coding for tumor antigens recognized by cytolytic T lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2249693

30 September 2017

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2249693

30 September 2017

T cell clonal anergy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2249693

28 June 2018

Role of apoptosis in the regulation of virus-induced T cell responses, immune suppression, and memory

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2249693

28 June 2018

Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2249693

21 September 2018

Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/10415076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residues

1 reference

https://pubmed.ncbi.nlm.nih.gov/10415076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report

1 reference

https://pubmed.ncbi.nlm.nih.gov/10415076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/10415076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/10415076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression

1 reference

https://pubmed.ncbi.nlm.nih.gov/10415076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

1 reference

Europe PubMed Central

14 August 2017

1 reference

Europe PubMed Central

14 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36473826&oldid=1634332502"